The press releases posted on this Site are current
only as of their date. Nventa Biopharmaceuticals does not update its press releases
solely due to a change in the facts described in old press releases.
Old press releases are provided only to give readers a sense of
past developments and should not be taken as implying that the information
contained in them remains accurate. Prior to June 1 2006, Nventa Biopharmaceuticals Corporation was named Stressgen Biotechnologies Corporation.
| November 22 , 2006 |
NVENTA PROVIDES CLINICAL DEVELOPMENT STRATEGY UPDATE ON LEAD PROGRAM HSPE7
[Read
more]
 Download a PDF file of this release
|
| |
| November 14 , 2006 |
NVENTA BIOPHARMACEUTICALS CORPORATION ANNOUNCES THIRD QUARTER 2006 FINANCIAL RESULTS
Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today financial results for the third quarter ended September 30, 2006.
[Read
more]
Download a PDF file of this release
|
| |
| November 8 , 2006 |
NVENTA™ PRESENTATION AT RODMAN & RENSHAW 8TH ANNUAL HEALTHCARE CONFERENCE
The audio portion of the presentation is available by replay on the Rodman & Renshaw website at http://www.wsw.com/webcast/rrshq10/tsx.nvn/. The replay of the webcast will be available for 90 days after the live presentation.
|
| |
| November 2 , 2006 |
NVENTA™ CEO TO PRESENT AT RODMAN & RENSHAW 8TH ANNUAL HEALTHCARE CONFERENCE
[Read
more]
Download a PDF file of this release
|
| |
| September 7 , 2006 |
 NVENTA™ ANNOUNCES PRESENTATION OF POSITIVE HSPE7 DATA FROM CLINICAL TRIAL IN GENITAL WARTS -- Eighty-One Percent of Patients Showed Complete Response or Marked Improvement
[Read
more]
Download a PDF file of this release
Download a PDF file of the HspE7 poster
|
| |
| September 6 , 2006 |
 NVENTA™ PRESENTS FIRST DATA ON HSPE7 WITH ADJUVANTS AT INTERNATIONAL CONFERENCE -- Data Show Greater Potency of HspE7 in Combination with Adjuvants --
[Read
more]
Download a PDF file of this release
Download a PDF file of the HPV-2006 poster
|
| |
| August 23 , 2006 |
NVENTA™ SIGNS SUPPLY AGREEMENT FOR PROPRIETARY ADJUVANT FOR USE WITH HSPE7
[Read
more]
Download a PDF file of this release
|
| |
| August 9 , 2006 |
NVENTA™ BIOPHARMACEUTICAL CORPORATION ANNOUNCES SECOND QUARTER 2006 FINANCIAL RESULTS
[Read
more]
Download a PDF file of this release
|
| |
| August 4 , 2006 |
NVENTA™ TO RECEIVE $2.8 MILLION FROM ESCROW ACCOUNT
[Read
more]
Download a PDF file of this release
|
| |
| June 28 , 2006 |
NVENTA™ PRESIDENT'S PRESENTATION AT ANNUAL GENERAL MEETING
Download the PowerPoint slideshow file of Nventa Biopharmaceuticals President and CEO Gregory McKee's AGM presentation (900 Kb, requires Microsoft PowerPoint to view)
|
| |
| June 20 , 2006 |
NVENTA™ STRENGTHENS PATENT PORTFOLIO WITH TWO NEW EUROPEAN PATENTS FOR HPV-RELATED DISEASES
[Read
more]
Download a PDF file of this release
|
| |
| June 15 , 2006 |
NVENTA™ ANNOUNCES POSITIVE HSPE7 DATA FROM NCI-SPONSORED CLINICAL TRIAL IN HIV-POSITIVE PATIENTS - First Clinical Evidence that HspE7 May Have Activity in Immunocompromised Patients
[Read
more]
Download a PDF file of this release
|
| |
| June 7 , 2006 |
NVENTA™ GRANTED EUROPEAN PATENT COVERING HEAT SHOCK PROTEIN FUSION TO TREAT INFLUENZA
[Read
more]
Download a PDF file of this release
|
| |
| June 1 , 2006 |
STRESSGEN CHANGES NAME TO NVENTA BIOPHARMACEUTICALS CORPORATION - “From Insight to Impact”
[Read
more]
Download a PDF file of this release
|
| |
| May 11 , 2006 |
STRESSGEN BIOTECHNOLOGIES ANNOUNCES FIRST
QUARTER 2006 FINANCIAL RESULTS
[Read
more]
Download a PDF file of this release
|
| |
| May 2 , 2006 |
STRESSGEN TO PRESENT AT UPCOMING BIOFINANCE 2006 CONFERENCE IN TORONTO
[Read
more]
Download a PDF file of this release
|
| |
| April 19, 2006 |
STRESSGEN PROVIDES CORPORATE AND HSPE7 PROGRAM UPDATES
[Read
more]
Download a PDF file of this release |
| |
| April 18, 2006 |
STRESSGEN ANNOUNCES NEW HEAD OF RESEARCH & DEVELOPMENT
- Position Strengthens Senior Management Team -
[Read
more]
Download a PDF file of this release
|
| |
| April 6, 2006 |
STRESSGEN ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS
[Read
more]
Download a PDF file of this release
|
| |
| March 29, 2006 |
TSX ISSUES BULLETIN CONFIRMING SUBSTITUTIONAL
LISTING
[Read
more]
Download a PDF file of this release
|
| |
| March 24, 2006 |
STRESSGEN COMPLETES CORPORATE TRANSACTION
- Company to Receive Up to $9.25 Million in Non-Dilutive Capital -
[Read
more]
Download a PDF file of this release
|
| |
| March 22, 2006 |
STRESSGEN BIOTECHNOLOGIES ANNOUNCES 2005 FINANCIAL
RESULTS
- Successful Initiatives Implemented in 2005 Strengthen the Company -
[Read
more]
Download a PDF file of this release
|
| |
| March 16, 2006 |
STRESSGEN OBTAINS SECURITYHOLDER APPROVAL FOR CORPORATE TRANSACTION
- Company to Receive Up to $9.25 Million in Non-Dilutive Funding -
[Read
more]
Download a PDF file of this release
|
| |
March 2 , 2006 |
